YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3 - TransCon CNP NDA submission for achondroplasia planned for Q1 2025 ...
All amounts are in USD unless stated otherwise BROSSARD, QC, Nov. 14, 2024 /PRNewswire/ - G Mining Ventures Corp. ("GMIN" or the "Corporation" or "we") (TSX: GMIN) (OTCQX: GMINF) is pleased ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback